Physician profile
Tamer Ghaly
NPI 1982882239
$6,831.80
in general payments reported to CMS, 2019-2025
48 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $462 · 2021: $358 · 2022: $1,097 · 2023: $947 · 2024: $1,736 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,762.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,148.80 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Amgen INC. | $882.74 | 2022-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $531.41 | 2019-2021 | |
| Bioventus LLC | $379.16 | 2022 | |
| Vertos Medical, INC. | $358.59 | 2024 | Mild Device Kit |
| Spr Therapeutics, INC | $302.63 | 2024 | Sprint Pns System |
| Heron Therapeutics, INC. | $249.99 | 2021-2023 | Aponvie |
| Daiichi Sankyo INC. | $238.68 | 2019 | |
| Abbvie INC. | $226.32 | 2023-2024 | |
| Medtronic, INC. | $193.92 | 2022-2023 | Intellis Adaptivestim |
| Pfizer INC. | $173.75 | 2019-2021 | |
| Depuy Synthes Sales INC. | $164.84 | 2023-2025 | Monovisc, Orthovisc |
| Biotronik Nro, INC. | $146.80 | 2025 | Prospera |
| Nevro Corp. | $135.20 | 2024 | Senza |
| Intuitive Surgical, INC. | $134.85 | 2025 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamer Ghaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.